News & Updates

Ibrutinib (Imbruvica▼): reports of ventricular tachyarrhythmia; risk of hepatitis B reactivation and of opportunistic infections
Temporarily discontinue ibrutinib in patients who develop symptoms suggestive of ventricular arrhythmia and assess benefit-risk before restarting therapy.

Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration
Central serous chorioretinopathy is a retinal disorder that has been linked to the systemic use of corticosteroids. Recently, it has also been reported after local administration of corticosteroids via inhaled and intranasal, epidural, intra-articular, topical dermal, and periocular routes.

Adrenaline auto-injectors: updated advice after European review
It is recommended that 2 adrenaline auto-injectors are prescribed, which patients should carry at all times.

Letters sent to healthcare professionals in July 2017
Letters were sent about ibrutinib, daclizumab, aflibercept, valproate medicines, and arsenic trioxide.

Medical Device Alerts issued in July 2017
An alert was recently issued about Prismaflex haemofiltration machines.
MHRA is advising consumers not to use Ayurvedic herbal medicine Shwasa Sanjeevani as it has been found to contain dexamethasone, a prescription only medicine which has not been declared on the packaging.

As set out in our April 2016 CNHC news update, the National Institute for Health and Care Excellence (NICE) has been revising its guidelines for low back pain and sciatica. NICE has now completed its work and published the final guideline on 30 November 2016. The good news for some CNHC registrants is that massage has been included in the guideline, under a recommendation for manual therapies, when used as part of a multi-treatment package including exercise. Group yoga classes have also been included.

Click to download PDF Document